Skip to content

Plant-Based Dietary Intervention in Type 2 Diabetes

Plant-Based Dietary Intervention in Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00276939
Enrollment
99
Registered
2006-01-13
Start date
2003-09-30
Completion date
2006-07-31
Last updated
2012-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Diabetes Mellitus, Type 2, Diet, Vegetarian, Diet, Fat-Restricted, Glycemic Index

Brief summary

The purpose of the study is to assess whether, in individuals with type 2 diabetes, a low-fat, vegan diet improves blood glucose control more effectively than a control diet based on current American Diabetes Association (ADA) guidelines. The principal measure is hemoglobin A1c. Cardiovascular risk factors and dietary acceptability are also assessed. The study duration is 22 weeks with a one-year follow-up.

Detailed description

Preliminary evidence suggests that low-fat, vegetarian regimens similar to those used to reverse coronary artery blockages may have a significant beneficial effect on type 2 diabetes, as demonstrated by reductions in fasting serum glucose concentrations and medication use. We therefore randomly assigned 99 individuals with type 2 diabetes to either a low-fat, vegan diet or a diet based on current American Diabetes Association guidelines for 22 weeks with a one-year follow-up period. The principal dependent measure is hemoglobin A1c. Cardiovascular risk factors are also being tracked, as is dietary acceptance.

Interventions

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Diabetes Action Research and Education Foundation
CollaboratorOTHER
George Washington University
CollaboratorOTHER
University of Toronto
CollaboratorOTHER
Physicians Committee for Responsible Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Type 2 Diabetes Mellitus

Exclusion criteria

* hemoglobin A1c values \<6.5% or \>10.5% * use of insulin for \> 5 years * tobacco use within the preceding 6 months * consumption of more than 2 alcoholic beverages per day * current drug abuse * pregnancy * unstable medical status * current use of a low-fat, vegetarian diet.

Design outcomes

Primary

MeasureTime frame
Hemoglobin A1c22 weeks

Secondary

MeasureTime frame
Body weight22 weeks
Plasma lipid concentrations22 weeks
Urinary albumin22 weeks
Dietary Acceptability22 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026